Literature DB >> 35547450

An Atypical Presentation of West Nile Virus With Successful Treatment After Plasma Exchange and Intravenous Immunoglobulin.

Kevin Malone1, Rahul Abraham2, Grace Mccurdy2, Vishal Devarkondal2, Christopher M Stevens3.   

Abstract

West Nile (WN) disease is a relatively rare arboviral virus. Neuroinvasive cases of WN account for less than 1% of the total cases. The case described had difficult symptomatology and radical presentation, which included ascending paralysis. To date, there have been very few reports of West Nile cases that present with ascending paralysis. We describe the case of a 63-year-old white male who presented with a fever and proximal muscle weakness in the thighs and legs that rapidly worsened and ascended, eventually resulting in diaphragmatic paralysis. He was intubated after respiratory failure and given intravenous immunoglobulin and plasma exchange. The patient remained ventilated with persistent weakness. However, this improved after intravenous immunoglobulin and plasma exchange therapy. This case serves as a reminder to keep the diagnosis of WN on the differential, a primer on advanced treatments in the setting of aggressive atypical WN, and a lesson on similarly presenting diseases and distinguishing characteristics that may help rule out these diseases from WN.
Copyright © 2022, Malone et al.

Entities:  

Keywords:  adem; guillain; ivig; neuroinvasive; nile; paralysis; plasmapheresis; steroids; west; west nile

Year:  2022        PMID: 35547450      PMCID: PMC9090226          DOI: 10.7759/cureus.24003

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  28 in total

1.  Rash as a prognostic factor in West Nile virus disease.

Authors:  Gregory D Huhn; Mark S Dworkin
Journal:  Clin Infect Dis       Date:  2006-08-01       Impact factor: 9.079

2.  West Nile fever characteristics among viremic persons identified through blood donor screening.

Authors:  Shimian Zou; Gregory A Foster; Roger Y Dodd; Lyle R Petersen; Susan L Stramer
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

3.  Posterior reversible encephalopathy syndrome resulting from Guillain-Barré-like syndrome secondary to West Nile virus infection.

Authors:  Alon Abraham; Sari Ziv; Vivian E Drory
Journal:  J Clin Neuromuscul Dis       Date:  2011-03

4.  The Role of Therapeutic Plasma Exchange in the Treatment of Childhood Intoxication: A Single-Center Experience.

Authors:  Murat Özkale; Yasemin Özkale
Journal:  Pediatr Crit Care Med       Date:  2020-11       Impact factor: 3.624

5.  Plasma exchange for severe attacks of CNS demyelination: predictors of response.

Authors:  M Keegan; A A Pineda; R L McClelland; C H Darby; M Rodriguez; B G Weinshenker
Journal:  Neurology       Date:  2002-01-08       Impact factor: 9.910

6.  West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003.

Authors:  Amy V Bode; James J Sejvar; W John Pape; Grant L Campbell; Anthony A Marfin
Journal:  Clin Infect Dis       Date:  2006-03-30       Impact factor: 9.079

Review 7.  Idiopathic CD4 lymphopenia associated with neuroinvasive West Nile disease: case report and review of the literature.

Authors:  Alex McBath; Rebecca Stafford; Suresh J Antony
Journal:  J Infect Public Health       Date:  2013-11-11       Impact factor: 3.718

Review 8.  West Nile virus: review of the literature.

Authors:  Lyle R Petersen; Aaron C Brault; Roger S Nasci
Journal:  JAMA       Date:  2013-07-17       Impact factor: 56.272

9.  Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice.

Authors:  David Ben-Nathan; Shlomo Lustig; Guy Tam; Shahar Robinzon; Shraga Segal; Bracha Rager-Zisman
Journal:  J Infect Dis       Date:  2003-06-23       Impact factor: 5.226

10.  Lazarus Effect of High Dose Corticosteroids in a Patient With West Nile Virus Encephalitis: A Coincidence or a Clue?

Authors:  A Arturo Leis; David J Sinclair
Journal:  Front Med (Lausanne)       Date:  2019-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.